Allergies News and Research

Latest Allergies News and Research

A large, observational, household-based, remote cohort study of SARS-CoV-2 infection and transmission in households with children

Researchers designed a cohort-based surveillance study to identify risk factors for SARS-CoV-2 infection and its household transmission among children and individuals with asthma and allergic diseases.

13 Jul 2022

University of Oxford begins recruiting for Phase I trial of new TB vaccine

The University of Oxford has begun recruiting for a Phase I trial with a tuberculosis vaccine in human volunteers at Oxford to develop a new way to test the efficacy of future TB vaccines - with the first volunteers being challenged today (Wednesday).

12 Jul 2022

NIH launches clinical trial evaluating an experimental vaccine to prevent Nipah virus infection

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an investigational vaccine to prevent infection with Nipah virus.

11 Jul 2022

Universal influenza B vaccine confers robust and sustained cross-immune protection

A new universal flu vaccine protects against influenza B viruses, offering broad defense against different strains and improved immune protection, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

8 Jul 2022

Research reveals increase in prescriptions of specialized infant formula

New research published in Clinical and Experimental Allergy reveals that prescriptions of specialized infant formula have increased in recent years in England, Norway, and Australia, with rates over 10-fold what would be expected for the number of children with milk allergies.

7 Jul 2022

Early food intervention can reduce the risk of allergies in children

Letting your baby taste foods that contain peanuts, eggs, milk and wheat from the age of three months can reduce the risk of allergies in children.

6 Jul 2022

Scientists discover how a protein and enzymes interact to allow hepatitis A virus replication

The viral replication cycle is crucial for a virus to spread inside the body and cause disease. Focusing on that cycle in the hepatitis A virus (HAV), UNC School of Medicine scientists discovered that replication requires specific interactions between the human protein ZCCHC14 and a group of enzymes called TENT4 poly(A) polymerases.

4 Jul 2022

New discovery could lead to more effective treatments for asthma sufferers

New research led by Edith Cowan University has made an important discovery that could lead to more effective treatments for the world's 262 million asthma sufferers.

4 Jul 2022

HIV accelerates epigenetic aging soon after initial HIV infection

HIV has an "early and substantial" impact on aging in infected people, accelerating biological changes in the body associated with normal aging within just two to three years of infection, according to a study by UCLA researchers and colleagues.

1 Jul 2022

Stopping a pervasive bacterium that makes millions sick each year

As we head outdoors this summer, scientists are working to clip the long, flexible appendages that enable the common bacterium Campylobacter jejuni to make its way from undercooked poultry and natural waterways into our intestinal tract where it makes millions of us sick each year.

1 Jul 2022

Novel universal flu vaccine confers protection against different strains and subtypes of influenza A viruses

A new universal flu vaccine constructed with key parts of the influenza virus offers broad cross protection against different strains and subtypes of influenza A viruses in young and aged populations, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

30 Jun 2022

The risk of SARS-CoV-2 infection and disease severity in a cohort of severe asthmatics treated with biologics

Researchers assessed the risk of SARS-CoV-2 infection in asthma patients taking biologics.

29 Jun 2022

Phase 1 clinical trial of new influenza vaccine begins at NIH Clinical Center in Bethesda

A Phase 1 clinical trial of a novel influenza vaccine has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland.

28 Jun 2022

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

The virus that causes COVID-19 undertakes a massive takeover of the body's fat-processing system, creating cellular storehouses of fat that empower the virus to hijack the body's molecular machinery and cause disease.

28 Jun 2022

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Rensselaer Polytechnic Institute researchers Gaetano Montelione and Christopher Cioffi will use a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a low-dose, oral COVID antiviral drug that can be administered at home.

27 Jun 2022

Techniques used in weather forecasting can be repurposed to assess risk of COVID-19 exposure

Techniques used in weather forecasting can be repurposed to provide individuals with a personalized assessment of their risk of exposure to COVID-19 or other viruses, according to new research published by Caltech scientists.

23 Jun 2022

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

With the SARS-CoV-2 pandemic ongoing, researchers at University of California San Diego School of Medicine, in collaboration with the American Academy of Allergy Asthma and Immunology, will continue a national study to evaluate the safety of COVID-19 vaccinations during pregnancy, and monitor immune response for mother and baby following vaccinations.

23 Jun 2022

Childhood bronchitis increases the risk of lung diseases in adult life

Bronchitis in early childhood has been found to increase the risk of lung diseases in middle age according to research from the Allergy and Lung Health Unit at the University of Melbourne.

21 Jun 2022

How specific comorbidities impact severity of COVID-19

Researchers identify the association between severe COVID-19 and specific comorbidities.

20 Jun 2022

UTSW study provides a potential avenue for the development of new antivirals against influenza

A collaborative study from UT Southwestern scientists has identified a new function for a protein called TAO2 that appears to be key to inhibiting replication of the influenza virus, which sickens millions of individuals worldwide each year and kills hundreds of thousands.

20 Jun 2022

Allergies News and Research

Latest Allergies News and Research

A large, observational, household-based, remote cohort study of SARS-CoV-2 infection and transmission in households with children

University of Oxford begins recruiting for Phase I trial of new TB vaccine

NIH launches clinical trial evaluating an experimental vaccine to prevent Nipah virus infection

Universal influenza B vaccine confers robust and sustained cross-immune protection

Research reveals increase in prescriptions of specialized infant formula

Early food intervention can reduce the risk of allergies in children

Scientists discover how a protein and enzymes interact to allow hepatitis A virus replication

New discovery could lead to more effective treatments for asthma sufferers

HIV accelerates epigenetic aging soon after initial HIV infection

Stopping a pervasive bacterium that makes millions sick each year

Novel universal flu vaccine confers protection against different strains and subtypes of influenza A viruses

The risk of SARS-CoV-2 infection and disease severity in a cohort of severe asthmatics treated with biologics

Phase 1 clinical trial of new influenza vaccine begins at NIH Clinical Center in Bethesda

SARS-CoV-2 virus undertakes a massive takeover of the body's fat-processing system

Rensselaer scientists secure $3.5 million grant to develop a low-dose, oral COVID antiviral drug

Techniques used in weather forecasting can be repurposed to assess risk of COVID-19 exposure

Researchers continue a national study to evaluate COVID-19 vaccination safety pre-and post-delivery

Childhood bronchitis increases the risk of lung diseases in adult life

How specific comorbidities impact severity of COVID-19

UTSW study provides a potential avenue for the development of new antivirals against influenza

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Allergies News and Research

Latest Allergies News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in